NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors

Clinical trial NCT05131763 · UNKNOWN

Trial details

NCT number: NCT05131763
Sponsor: Fudan University
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Glioblastoma Medulloblastoma Colon Cancer

Start date: 2021-03-01
Primary completion: 2022-12-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.